Fir Tree Capital Management
TLSIW icon

Fir Tree Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Fir Tree Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-41,665
Closed -$41K – 592
2021
Q2 		$41K Hold
41,665
– – ﹤0.01% 544
2021
Q1 		$46K Buy
+41,665
New +$75.2K ﹤0.01% 421

Other funds holding TLSIW

Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Linden Advisors
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Spring Creek Capital
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Fir Tree Capital Management's TLSIW Position: Q3 2021 in Review

Fir Tree Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2021, closing a stake of 41,665 shares — an estimated $41K sold.

Fir Tree Capital Management first reported a position in TLSIW in Q1 2021 and held it in 2 quarters. The position peaked at $46K in Q1 2021. 25 funds tracked by Wall St. Rank hold TLSIW as of Q3 2021.

  • Fir Tree Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2021 after selling out during the quarter.
  • Fir Tree Capital Management sold 41,665 TriSalus Life Sciences Warrant shares in Q3 2021, an estimated $41K.
  • Fir Tree Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 2 quarters.
  • Fir Tree Capital Management's TriSalus Life Sciences Warrant position peaked at $46K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2021.

Based on Fir Tree Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.